G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54 | -42.6% | 37,726 | +0.5% | 0.00% | 0.0% |
Q2 2023 | $94 | -10.5% | 37,553 | -4.2% | 0.00% | 0.0% |
Q1 2023 | $105 | -58.8% | 39,214 | -16.6% | 0.00% | -66.7% |
Q4 2022 | $255 | -99.9% | 47,047 | +22.6% | 0.00% | -50.0% |
Q3 2022 | $479,000 | +154.8% | 38,363 | +0.5% | 0.01% | +200.0% |
Q2 2022 | $188,000 | -34.9% | 38,156 | +0.4% | 0.00% | 0.0% |
Q1 2022 | $289,000 | -39.3% | 38,014 | -18.5% | 0.00% | -33.3% |
Q4 2021 | $476,000 | -40.5% | 46,669 | -21.7% | 0.00% | -25.0% |
Q3 2021 | $800,000 | -9.6% | 59,576 | +47.7% | 0.00% | 0.0% |
Q2 2021 | $885,000 | -18.8% | 40,347 | -10.9% | 0.00% | -33.3% |
Q1 2021 | $1,090,000 | +102.2% | 45,294 | +51.3% | 0.01% | +100.0% |
Q4 2020 | $539,000 | -22.6% | 29,940 | -50.3% | 0.00% | -25.0% |
Q3 2020 | $696,000 | +66.9% | 60,263 | +250.6% | 0.00% | +33.3% |
Q2 2020 | $417,000 | +74.5% | 17,187 | -20.8% | 0.00% | +50.0% |
Q1 2020 | $239,000 | +59.3% | 21,693 | +344.2% | 0.00% | +100.0% |
Q2 2019 | $150,000 | -53.8% | 4,884 | -75.0% | 0.00% | -66.7% |
Q1 2019 | $325,000 | -66.5% | 19,572 | -61.3% | 0.00% | -62.5% |
Q4 2018 | $970,000 | +128.8% | 50,635 | +418.9% | 0.01% | +100.0% |
Q2 2018 | $424,000 | – | 9,758 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |